Replek AD (XMAE:REPL) Treasury Stock : MKD-72 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Replek AD Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Replek AD's treasury stock for the quarter that ended in Dec. 2024 was MKD-72 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Replek AD Treasury Stock Historical Data

The historical data trend for Replek AD's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Treasury Stock Chart

Replek AD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Treasury Stock

Get a 7-Day Free Trial

-41.02

-72.16

Replek AD Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Treasury Stock	Get a 7-Day Free Trial															-	-72.16	-	-	-72.16

Replek AD Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Replek AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kozle 188, Skopje, MKD

Website

https://www.replek.mk

Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.